ISRCTN61884303已完成4 期
Immunogenicity after the first and second dose of the BNT162b2 mRNA Covid-19 vaccine: real-world evidence from Greece
Georgios Gennimatas General Hospital0 个研究点目标入组 425 人开始时间: 2021年2月10日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 425
研究概览
简要总结
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34397348/ (added 06/03/2024) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35746484/ (added 06/03/2024)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Age of 18 - 69 years
- •2. Without previously known SARS-CoV-2 infection, or
- •3. With previous PCR-confirmed SARS-CoV-2 infection one to 4.5 months prior to vaccination
排除标准
- •1. Occurence of any other vaccination 4 weeks prior to enrollment
- •2. Pregnancy or breastfeeding
- •3. Participation in any other clinical trial
研究者
相似试验
进行中（未招募）
1 期
Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and AboveRespiratory Syncytial Virus (RSV)NCT06642558MAXVAX Biotechnology Limited Liability Company522
已完成
2 期
Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in AdultsOrthomyxoviridae InfectionMyxovirus InfectionInfluenzaNCT00703651Sanofi Pasteur, a Sanofi Company1,150
已完成
3 期
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A VaccineHepatitis A VaccineNCT03654664Boryung Pharmaceutical Co., Ltd119
已完成
2 期
A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) TherapyHepatitis B, ChronicNCT05276297GlaxoSmithKline174
已完成
不适用
The 6-in-1 Vaccine StudyVaccination against diphtheria, tetanus, pertussis, polio, haemophilus influenza B (Hib) and hepatitis B virus (HBV)Infections and InfestationsISRCTN85819697niversity of Oxford194